AMSTERDAM – Eli Lilly and Co (LLY.N) said on Monday it will invest $3 billion to build a new manufacturing plant in the Netherlands, expanding capacity for its experimental weight-loss pill orforglipron and other oral treatments as it races to meet soaring demand. The Indianapolis-based drugmaker is ramping up production of its key metabolic drugs,…
The manufacturing facility is expected to create 3,600 jobs WILMINGTON: AstraZeneca is investing $4.5 billion in its new manufacturing facility in Virginia, a proposed increase of $500 million to support the enhanced manufacturing capability of a broader range of medicines including cancer treatments. This is part of the historic $50 billion investment announced in July…
LONDON: AstraZeneca today announced $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is expected to create tens of thousands of new, highly skilled direct and indirect jobs across the country powering growth and delivering next generation medicines for patients in America…